chrisvoncsefalvay/vaers-outcomes huggingface dataset:
- Received first dose of mRNA vaccine on Thursday 4/8/21  - Febrile and lethargic on 4/9/21  - Chest pain started 4/10/21, radiated to arms bilaterally, associated with diaphoresis, went to ED  - Dx with lateral ST elevation MI, positive and rising high-sensitivity troponin, taken to cath lab, clean coronary arteries, echo showed EF 45% with apical lateral hypokinesis  - stayed for 24 hours in hospital, discharged pain free  - seen in cardiology clinic at Medical Center on Friday 4/9/21.  EF had normalized, ECG had normalized, no residual symptoms
Developed chickenpox : has > 30 lesions. Afebrile around 98.6. BP 102/74, P96, R20
Side effects of previous vaccinations were painful; This spontaneous case was reported by a non-health professional and describes the occurrence of IMMUNISATION REACTION (Side effects of previous vaccinations were painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   In August 2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. In September 2021, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2022, received fourth dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Side effects of previous vaccinations were painful). At the time of the report, IMMUNISATION REACTION (Side effects of previous vaccinations were painful) outcome was unknown.            Concomitant Medication use information was not provided by reporter.  Treatment Medication use information was not provided by reporter.
Information has been received from a certified medical assistant referring to a 9 week old female patient. Information about concurrent condition, medical history and concomitant therapy was not reported. The medical assistant reported the patient was vaccinated with the first dose of RECOMBIVAX HB (lot # and dose not reported) and ROTATEQ (lot # and dose not reported) on 27-APR-2016 when 6 weeks old. Then on 12-MAY-2016, the patient was vaccinated with the second dose of RECOMBIVAX HB (lot # and dose not reported) and ROTATEQ (lot # and dose not reported) when 9 weeks old. No adverse symptoms were reported. It was unspecified if the patient sought medical attention. Additional information has been requested.
Fever101-102 for 18 hrs post injection beginning 10 hrs after injection  Severe body /joint aches for 12 hrs beginning 18 hrs post injection
after the first vaccine my menstrual cycle was late two weeks; had horrible cramps which never happens/ horrible menstrual cramps; migraines; lower back pain; menstrual cycle changed to heavy flows after the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left (Lot number: EP7534) as dose 1,single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: MENSTRUATION DELAYED (non-serious) with onset 27Mar2021, outcome "unknown", described as "after the first vaccine my menstrual cycle was late two weeks"; DYSMENORRHOEA (non-serious) with onset 27Mar2021, outcome "unknown", described as "had horrible cramps which never happens/ horrible menstrual cramps"; MIGRAINE (non-serious) with onset 27Mar2021, outcome "unknown", described as "migraines"; BACK PAIN (non-serious) with onset 27Mar2021, outcome "unknown", described as "lower back pain"; HEAVY MENSTRUAL BLEEDING (non-serious) with onset 27Mar2021, outcome "unknown", described as "menstrual cycle changed to heavy flows after the vaccine". Therapeutic measures were not taken as a result of menstruation delayed, dysmenorrhoea, migraine, back pain, heavy menstrual bleeding.  Additional Information- After the first vaccine my menstrual cycle was late two weeks and had horrible cramps which never happens. Although I was on birth control pill and I always get my period on time. This did not happen. After my second dose, my menstrual cycle was two weeks earlier and same thing as before heavy bleeding, horrible menstrual cramps, lower back pain and migraines. This never happens with me usually its none to mild back aches. But my menstrual cycle changed to heavy flows after the vaccine.   No follow-up attempts are possible. No further information is expected.
Soon after receiving the vaccine, I noticed a patch of redness like a rash on my upper abdomen. At first, I disregarded it as a rash until it became painful and did not respond to a hydrocortisone cream that I used on it. It also began to tingle and spread around my rib cage and I began to notice the tingling and pain spreading to other parts of my body like shoulder and legs. I have had shingles in the past and thought it may be that, but the pain continued and got worse. Although I have a sedentary job, it was still too painful to move and work. I eventually called my doctor who confirmed that I had shingles. He prescribed valacyclovir for the shingles and a medication for the pain. On the tenth day of the antibiotic, I suddenly noticed on my left side that I had a huge patchy red rash on the front of my left thigh that was extremely painful with a burning sensation that lasted for around 24 hours before disappearing.
pt was on home hospice (facility name unknown) when he was brought to the ED and admitted for increasing SOB; found to be severely anemic with tachycardia, tachypnea, and uncontrolled pain; DNR/CC order; pt admitted to inpatient hospice where he passed away; pt passed away on 11/2/21 and his COVID test came back positive on 11/4/21 after death
The patient recieved the janssen covid vaccine at about 2:35pm. Patient passed out by his chair. It was about a few minutes after getting the janssen covid vaccine.  We called 911. I went to assist him and was alert. He sat on the floor and I checked his pulse. He was pale. I offered him water which he drank after about 5 minutes. The EMT's arrived after a few minutes and  checked him out. Took his vitals and looked him over. The patient left after 20 minutes.
Patient presented with mucositis, lower extremity rash, and pancytopenia WBC 0.41, ANC 0.25, Plt 39. CBC on 3/4 with WBC 10 and Plt 254. BM biopsy hypocellular marrow with trilineage hypoplasia.  2 days after admission patient developed e. coli bacteremia from neutropenia.
Patient reports sx beginning hours after vaccination. Sx include: rash on R arm and bilateral legs, GI upset, intermittent Itching all over her body, swollen, bulging veins all over, L arm weakness and pain. She did not seek medical attention even though she was advised. She said there was too much traffic. She was also advised to take Benadryl and she states she didn't know what that was and didn't have any. Most of the symptoms have subsided and has an appointment to see her doctor tomorrow 02/15/2022 at 8am. I advised her to call me after her appointment.
1627: informed patient was experiencing nausea 1630: BP:118/68; P:72; RR:18; patient sitting in waiting area after receiving COVID-19 vaccine; stated she was fine but had some nausea; had eaten at ~1100 today and feeling fine; stated hx of Lupus and gave names of meds she had taken earlier; stated she had been cleared to receive vaccine by PCP and Rheumatologist 1635: BP:140/88; P:68; RR:18; patient began to slump down on chair and left hand began to go limp - 911 activated. Patient did not have LOC and tears rolled down her eyes; began to lose color on face; patient placed on cot in supine position and removed jacket she was wearing. Skin was warm but not clammy/diaphoretic. 1640:BP: 122/82; P:68; RR:18; patient lucid but began to slur words - continued to monitor, airway in tact and no LOC 1642: EMS arrival, report given to EMS and care transferred Blood sugar p/EMS: 80 1707: EMS departed, patient remained supine in cot; this nurse assisted patient from cot to a chair and patient did great. ~1720: Patient and her mom were escorted to her vehicle by another nurse  2013: This nurse called patient and she sounded wonderful; stated she was about to get showered; patient appreciative for f/u call.
On Aug 4 2008 my granddaughter received a chicken pox vaccine. She got very sick and broke out with a few bumps, -spots- she was taken to the doctors. The doctor stated that it was unlikely that the spots were chicken pox. I then came in contact with her on Friday Aug. 8th 2008. On Tuesday Aug. 14 2008 I thought I was coming down with a cold. On Wed. Aug 13th I started to break out with chicken pox. I have already had chicken pox as a child and it was a hard case of them. My 20 year old daughter that lives with me was also exposed to my granddaughter; she also broke out with chicken pox the same day I did and she also had chickenpox as a child. Today 8-18-08 I found 2 spots on my husband and he also had chicken pox as a child. There is evidently a serious problem with the chicken pox vaccine or at least that batch that my granddaughter received. Someone needs to pull a sample out of the same lot that my granddaughter received and it needs to be checked. I called the CDC and checked online and it is supposed to be VERY VERY RARE that a person can get chickenpox twice. I have 3 people in my household that have chicken twice, how is this possible? Has the virus mutated. Is the vaccine defective? SOMEONE NEEDS TO TAKE ACTION NOW! Our exposure is going to lead to to an outbreak of chicken pox. The news channel will be informed if there is no action taken. THE PUBLIC NEEDS TO KNOW!
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1816027, and expiry: 29-SEP-2021) dose was not reported, administered on 30-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 30-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine  was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20211049203, 20211049134 and 20211049738.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. During 2016, the patient was inoculated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about May 2016, the patient was treated and was diagnosed with herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
pt recv vax 13MAY96 & return to clinic on 15MAY w/moderate severe local rxn which involves almost entire upper lt arm;area is red, indurated, warm to touch & pt c/o itching to area;instructed to apply cool compress, elevate;
Vaccine, INFANRIX expired 9-6-14, given 9-9-14. No treatment, no reaction noted.
booster; She was kind of feeling bad; Shoulder was sore; Had a little tingling in her fingers; Breathing was kind of off a little bit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2), administration date 24Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE: 1), for COVID-19 immunization, reaction(s): "got the first two shots and there was no problem"; Bnt162b2 (DOSE: 2), for COVID-19 immunization, reaction(s): "got the first two shots and there was no problem". The following information was reported: IMMUNISATION (non-serious) with onset 24Nov2021, outcome "unknown", described as "booster"; FEELING ABNORMAL (non-serious) with onset Nov2021, outcome "unknown", described as "She was kind of feeling bad"; ARTHRALGIA (non-serious) with onset Nov2021, outcome "unknown", described as "Shoulder was sore"; PARAESTHESIA (non-serious) with onset Nov2021, outcome "unknown", described as "Had a little tingling in her fingers"; DYSPNOEA (non-serious) with onset Nov2021, outcome "unknown", described as "Breathing was kind of off a little bit".  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
This spontaneous report was received from a physician concerning an approximately 21 year old female patient with no pertinent medical history and no drug reactions or allergies. On unknown dates in 2003, the patient was vaccinated with GARDASIL series (lot number, expiry date, dose and route unspecified). Concomitant therapy included BEYAZ. On an unknown date in August 2012, the patient had a Pap test result that showed ASCUS (Atypical squamous cells of undetermined significance). On 20-AUG-2013, the patient had a Pap test result that showed LGSIL (Low grade squamous intraepithelial lesion), and positive for high risk HPV. The patient sought medical attention (office visit). No treatment was given. The patient was not recovered from the adverse events. The relatedness for the adverse events was unknown for GARDASIL. Additional information has been requested.
C/O of progressive weakness in arms & legs since vax 2Jan91, getting worse 28Jan91-resulting in MD visit, Hospitalized 1Feb91, Dx: Guillain Barre Disease
On an unspecified date, the pt received his 1st pediatric dose of Engerix-B. One month later, he was observed to have a "big dimple" in his leg (injection site). As of 6/20/01, the outcome of the event was unresolved.
This spontaneous case, initially received on 02-Nov-2016, was reported by a health professional and concerns a 70 year old patient. Weight: not provided; Height: not provided. Concomitant medication: Not reported. Administration of company suspect drug(s): On 16-Sep-2016 the patient received AFLURIA. Dose regimen: Not reported, Route of administration: Intramuscular, Batch number: WT54306. No additional suspect drugs. Adverse event description: On 23-Sep-2016, a nurse reported that a refrigerator went in and out of (temperature) range while there was flu vaccine in it. On 16-Sep-2016, doses were administered (special circumstances: drug administration error without adverse event, incorrect product storage without adverse event). Flu vaccine was first delivered to the vaccination facility on 15-Aug-2016. As the nurse reviewed the refrigerator temperature log, she stated that another excursion occurred on 15-Sep-2016. The doses arrived at 09:00 and were placed in a refrigerator that was at 10 degrees Celsius in the morning. Then the temperature remained at 9 degrees Celsius throughout the 15th and 51 doses were administered on the 16th at a flu clinic. The refrigerator was not back in range until 19-Sep-2016 at a temperature of 8 degrees Celsius. Temperature excursion identified: Log documentation reflected temperature excursions from 31-May-2016 to 23-Sep-2016 which ranged between 8 to 10 degrees Celsius. Vaccines had been given to patients between 31-May-2016 and 23-Sep-2016. On 04-Oct-2016, the remaining 42 doses of lot number WT54306 were discarded. The patients will be contacted for revaccination.
Patient had a local allergic reaction at the sight of injection. He had redness, a little swelling, and the area felt warm. Patient was seen by his physician and was given hydroxyzine to help with the allergic reaction and itching, and was given clindamycin in case of infection.
Pfizer vaccine given to pt from outside source - patient reported.   J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/26/2021 CANDIDA OF MOUTH J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 4/26/2021 NON KP HOSPICE CARE
Information has been received from the mother of a 14 year old female with no pertinent medical history or drug reactions/allergies, who on 18-JAN-2007 was vaccinated with Gardasil (0.5 ml). There was no concomitant medication. On 19-JAN-2007 the patient experienced hives, vomiting, dizziness and weight loss. At the time of this report, the patient's hives, vomiting, dizziness and weight loss persisted. Unspecified medical attention was sought and it was reported that the patient underwent blood tests (results not provided). Additional information has been requested.
headache; nauseated; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (nauseated) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced HEADACHE (headache), NAUSEA (nauseated) and FATIGUE (fatigue). At the time of the report, HEADACHE (headache), NAUSEA (nauseated) and FATIGUE (fatigue) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported. No treatment information was provided.
FELT SICK; This spontaneous report received from a patient via a company representative concerned an elderly male of an unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 1) (suspension for injection, route of administration was not reported, batch number: unknown and expiry: unknown) dose was not reported, 1 total, administered on an unspecified date for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26. cov2.s. (Dose number in series 1). The patient received additional dose covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of administration was not reported, batch number: unknown and expiry: unknown) dose was not reported, 01 total, administered on an unspecified date for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included macitentan for drug used for unknown indication.  On an unspecified date, the patient felt sick after his second covid-19 booster (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of felt sick was not reported. This report was non-serious. This case, involving the same patient is linked to 20220501877.
Lt arm swollen w/redness from upper shoulder to elbow, hot to touch, t104, dec w/APAP; these sx occurring x 2 days; Taken to MD & ATB were given & condition improved 26AUG91;
Shortly after receiving the Covid vaccine, I started having some minor but consistent pain in my right underarm. This is the same arm that the vaccine was given in.  I never had this before the vaccination.  I do not remember if it started after the first or second dose.  But it has remained but has moved from the direct armpit area to approximately 4" down on the inside of the arm.  The best I can describe it is a very sharp sudden pain that eases away.  It is not debilitating in any way but it is there and comes on suddenly.  I have mentioned it to several doctors but there seems to be no concern. I am not certain that it was caused by the vaccine but I never had this before the injection.  I feel it should be reported in case others are also experiencing it.
I started having very itchy feet and it gradually got hot and made it's way up my legs and on to my back and buttocks.  I had extremely itchy, angry, red, hot raised skin rash.  I have never had a rash like that.  Luckily, I did not have any problem with breathing. I took a cool shower and took 2 Claritin.  I also put Caladryl  on my skin.  This was 5 days and a couple of hours after taking the vaccine.  It seem  "Janssen COVID-19 Vaccine EUA"
This non-serious medically confirmed spontaneous report (initial receipt 20-Nov-2014) concerns a 70 year-old female patient who previously received flu vaccine (unknown if AFLURIA was administered) and experienced high temperatures, chills, fatigue, severe joint aches and generalized body pain (see case 2014046773). On 15-Oct-2014 at 14:50 hours, the patient received intramuscular AFLURIA vaccine (batch number 10149211A) 0.5mL. On the same day as the AFLURIA vaccine, 15-Oct-2014, some hours later, the patient experienced high temperatures, chills, fatigue, severe achiness especially in the joints, and all over generalized body pain for 24-36 hours. She stayed in bed for the entire evening. On 16-Oct-2014, she went to work where it was confirmed that her temperature was 101.7 degrees Fahrenheit. She was sent home where she remained in bed to rest. Her primary care provider was aware and she was advised to take acetaminophen or ibuprofen for the achiness. On 17-Oct-2014, she felt better. All the signs and symptoms resolved. Outcome was recovered on 17-Oct-2014.
Approximately 24 hrs after infection-redness, swelling, pain/cellulitis surrounding site-elbow.
Vomiting, weak, sore all over body for 24 hours after immunization.
I experienced achiness, then I started to get a head cold and had really bad chills and also had a fever.  I had recently traveled that what made me get tested. I got tested 11/02/2022 for at home COVID-19 test. I also took the COVID-19 test again two days later and it also came out positive.  I think I got a virus or cold that been going around.